This Hamburg IP boutique mainly works for companies from the pharmaceuticals, biotech and chemicals sectors in filing and opposition suits. Such notable companies as Monsanto and ExxonMobil are regular clients. Long-standing connections to Presspart gave rise to work for its subsidiary H&T. But the continuity in client relationships contrasted with staff fluctuation. Uexküll lost a partner accomplished in the chemicals sector, Wiegeleben. Two patent attorneys experienced in mobile communications already left last year. Staying attractive to younger partners will be the key to mastering the potential challenges brought by the UPC. After all, with its vast litigation experience in the pharmaceuticals sector, Uexküll is actually well set for the European court.
Patent litigation with a technical focus on pharmaceuticals, biotech and chemicals.
Albrecht von Menges, Peter Franck, Dr. Ulrich-Maria Gross, Dr. Heinz-Peter Muth (“much litigation experience and excellent preparation”, competitor).
15 patent attorneys
Dr. Peter Wiegeleben (to Eisenführ Speiser).
All-round IP practice focusing on patent prosecution with broad technical expertise. Opposition and nullity suits. Infringement proceedings with external litigators. Also trademarks and unfair competition.
Prosecution: filing and opposition suits for W. R. Grace, Chr. Hansen, Ivoclar, KRKA, Monsanto; filing for Helmholtz-Zentrum Geesthacht, Poly-Med, H&T Marsberg, Presspart.